12.39
-0.57(-4.40%)
Currency In USD
| Previous Close | 12.96 |
| Open | 12.82 |
| Day High | 12.83 |
| Day Low | 12.15 |
| 52-Week High | 14.06 |
| 52-Week Low | 4.02 |
| Volume | 969,693 |
| Average Volume | 1.03M |
| Market Cap | 668.75M |
| PE | 9.39 |
| EPS | 1.32 |
| Moving Average 50 Days | 11.5 |
| Moving Average 200 Days | 8.18 |
| Change | -0.57 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $361.86 as of January 13, 2026 at a share price of $12.39. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $115.1 as of January 13, 2026 at a share price of $12.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
GlobeNewswire Inc.
12 hours ago
GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025 using cash on hand. “This sig
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
GlobeNewswire Inc.
Jan 08, 2026 9:30 PM GMT
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax® (Anthrax Vaccine Adsorbed) in
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
GlobeNewswire Inc.
Jan 08, 2026 1:00 PM GMT
GAITHERSBURG, Md. and PARIS and ADDIS ABABA, Ethiopia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced a collaboration agreement with PANTHER to provide additional financial support to continue progressing the Af